Signalling through the receptor for advanced glycation end products (RAGE) is increased in acute asthma and correlates with symptom severity

Asger Bjerregaard (Hillerod, Denmark), Asger Bjerregaard, Celeste Porsbjerg, Lucy Barrett, Ingrid Laing, Siew-Kim Khoo, Markus Fally, Peter Le Souëf, Vibeke Backer, Philip Thompson, Svetlana Baltic

Source: International Congress 2016 – What's new in biomarker analysis?
Session: What's new in biomarker analysis?
Session type: Thematic Poster
Number: 904
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Asger Bjerregaard (Hillerod, Denmark), Asger Bjerregaard, Celeste Porsbjerg, Lucy Barrett, Ingrid Laing, Siew-Kim Khoo, Markus Fally, Peter Le Souëf, Vibeke Backer, Philip Thompson, Svetlana Baltic. Signalling through the receptor for advanced glycation end products (RAGE) is increased in acute asthma and correlates with symptom severity. Eur Respir J 2016; 48: Suppl. 60, 904

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Receptor of advanced glycation end products in childhood asthma exacerbation
Source: International Congress 2016 – Paediatric asthma: from amniotic fluid to dirty streets
Year: 2016



Advanced glycation end product (AGE), soluble receptor for AGE (sRAGE) and inflammation in smokers and mild/moderate chronic obstructive pulmonary disease (COPD)
Source: International Congress 2015 – Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases
Year: 2015

Increased expression of receptor for advanced glycation end products in COPD
Source: International Congress 2014 – Translational studies in COPD
Year: 2014


Receptor for advanced glycation end products (RAGE) is involved in cigarette smoke induced inflammation and emphysema
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015

Soluble RAGE is deficient in neutrophilic asthma and COPD
Source: Eur Respir J 2012; 39: 721-729
Year: 2012



TLR4 and NOD1 increase in stable COPD of increasing severity. Relationship with tissutal bacterial load
Source: International Congress 2016 – Inflammatory biomarkers in airway diseases
Year: 2016


Coagulation activity increases with disease severity in patients with asthma
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015

Reduced soluble receptor for advanced glycation end-products in COPD
Source: Eur Respir J 2011; 37: 516-522
Year: 2011



IL-25 receptor expression on basophil membrane is related to phenotype and severity of asthma
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015

Advanced glycation end products and its soluble receptor (sRAGE) are increased in chronic heart failure but not in chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD is not a pulmonary disease alone
Year: 2012


Correlation of inflammatory markers of disease with sputum neutrophilia in severe asthma
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015


Loss of receptor for advanced glycation end products (RAGE) in idiopathic pulmonary fibrosis
Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair
Year: 2007


Soluble receptor for advanced glycation end products (sRAGE) in asthmatic children as a new marker of the disease control
Source: Virtual Congress 2021 – Biomarkers and risk factors in childhood asthma
Year: 2021


Alterations in gene expression of RAGE and its sheddases in blood of COPD patients do not relate to decreased plasma (e)sRAGE levels
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014

Effect of tralokinumab on serum periostin and IgE levels in uncontrolled severe asthma
Source: International Congress 2015 – Advances in the future treatment of severe asthma
Year: 2015

Role of systemic inflammation mediated by IL-6 and TNF-alpha cytokines in chronic obstructive pulmonary disease and its progression: A three year follow up study
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013

Modulation of cytotoxic effects of histones by osteopontin
Source: International Congress 2015 – Inflammation and remodelling in lung disease
Year: 2015

Increased laminin deposition and expression of TGF-beta in bronchial biopsies of children with chronic obstructive respiratory diseases
Source: Annual Congress 2013 –Paediatric bronchology
Year: 2013


Induced sputum lipid mediators in severe asthma
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016

Various biomarkers of oxidative stress in patients with uncontrolled asthma
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013